Therapeutic strategies for well-differentiated papillary mesothelioma of the peritoneum. 2013

Young Ki Lee, and Hyun Jung Jun, and Ji Hae Nahm, and Tae Seop Lim, and Ji Soo Park, and Joong Bae Ahn, and Sun Young Rha, and Hyun Cheol Chung, and Hwa Eun Oh, and Ji-Sun Song, and Woo Ick Yang, and Hyo Song Kim
*Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea. hyosong77@yuhs.ac.

OBJECTIVE Well-differentiated papillary mesothelioma is an uncommon subtype of mesothelioma with a frequently indolent course, although it occasionally manifests in a more aggressive form. To establish a treatment strategy for this rare disease, we report the clinical characteristics and outcomes of 15 patients with well-differentiated papillary mesothelioma. METHODS All pathologically diagnosed well-differentiated papillary mesothelioma cases were reviewed between 1998 and 2012. RESULTS Of the 15 cases, 8 and 7 presented with single and multiple lesions, respectively. All cases with single lesions were asymptomatic, while 4 out of the 7 cases with multiple lesions were symptomatic. After tumor excision, none of the eight single-lesion cases experienced tumor recurrence. Among the other seven cases with multiple lesions, only one patient with disseminated lesions died due to disease burden. Five patients with multiple lesions received cisplatin-based intravenous or intraperitoneal chemotherapy, with a mix of complete (n= 2) and partial (n= 2) responses observed. Of particular note, one patient receiving cisplatin and pemetrexed combination chemotherapy experienced complete tumor resolution without any serious toxicity. CONCLUSIONS We recommend different treatment strategies based on the disease status. If the tumor is completely resectable, an excisional biopsy seems to be sufficient. If complete resection is unavailable for the asymptomatic patient with a localized tumor extent, close follow-up is an appropriate option. When the tumor is extensive or accompanied by symptoms, chemotherapy should be strongly considered.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D008297 Male Males
D008654 Mesothelioma A tumor derived from mesothelial tissue (peritoneum, pleura, pericardium). It appears as broad sheets of cells, with some regions containing spindle-shaped, sarcoma-like cells and other regions showing adenomatous patterns. Pleural mesotheliomas have been linked to exposure to asbestos. (Dorland, 27th ed) Mesotheliomas
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D010534 Peritoneal Neoplasms Tumors or cancer of the PERITONEUM. Peritoneal Carcinomatosis,Peritoneal Surface Malignancy,Carcinomatosis, Peritoneal,Malignancy, Peritoneal Surface,Neoplasm, Peritoneal,Peritoneal Carcinomatoses,Peritoneal Neoplasm,Peritoneal Surface Malignancies,Surface Malignancy, Peritoneal
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum

Related Publications

Young Ki Lee, and Hyun Jung Jun, and Ji Hae Nahm, and Tae Seop Lim, and Ji Soo Park, and Joong Bae Ahn, and Sun Young Rha, and Hyun Cheol Chung, and Hwa Eun Oh, and Ji-Sun Song, and Woo Ick Yang, and Hyo Song Kim
December 1990, AJR. American journal of roentgenology,
Young Ki Lee, and Hyun Jung Jun, and Ji Hae Nahm, and Tae Seop Lim, and Ji Soo Park, and Joong Bae Ahn, and Sun Young Rha, and Hyun Cheol Chung, and Hwa Eun Oh, and Ji-Sun Song, and Woo Ick Yang, and Hyo Song Kim
February 1996, European journal of cancer (Oxford, England : 1990),
Young Ki Lee, and Hyun Jung Jun, and Ji Hae Nahm, and Tae Seop Lim, and Ji Soo Park, and Joong Bae Ahn, and Sun Young Rha, and Hyun Cheol Chung, and Hwa Eun Oh, and Ji-Sun Song, and Woo Ick Yang, and Hyo Song Kim
January 2003, Przeglad lekarski,
Young Ki Lee, and Hyun Jung Jun, and Ji Hae Nahm, and Tae Seop Lim, and Ji Soo Park, and Joong Bae Ahn, and Sun Young Rha, and Hyun Cheol Chung, and Hwa Eun Oh, and Ji-Sun Song, and Woo Ick Yang, and Hyo Song Kim
June 2020, Cancers,
Young Ki Lee, and Hyun Jung Jun, and Ji Hae Nahm, and Tae Seop Lim, and Ji Soo Park, and Joong Bae Ahn, and Sun Young Rha, and Hyun Cheol Chung, and Hwa Eun Oh, and Ji-Sun Song, and Woo Ick Yang, and Hyo Song Kim
June 2002, Annals of diagnostic pathology,
Young Ki Lee, and Hyun Jung Jun, and Ji Hae Nahm, and Tae Seop Lim, and Ji Soo Park, and Joong Bae Ahn, and Sun Young Rha, and Hyun Cheol Chung, and Hwa Eun Oh, and Ji-Sun Song, and Woo Ick Yang, and Hyo Song Kim
October 2011, Journal de radiologie,
Young Ki Lee, and Hyun Jung Jun, and Ji Hae Nahm, and Tae Seop Lim, and Ji Soo Park, and Joong Bae Ahn, and Sun Young Rha, and Hyun Cheol Chung, and Hwa Eun Oh, and Ji-Sun Song, and Woo Ick Yang, and Hyo Song Kim
October 2001, The American journal of surgical pathology,
Young Ki Lee, and Hyun Jung Jun, and Ji Hae Nahm, and Tae Seop Lim, and Ji Soo Park, and Joong Bae Ahn, and Sun Young Rha, and Hyun Cheol Chung, and Hwa Eun Oh, and Ji-Sun Song, and Woo Ick Yang, and Hyo Song Kim
January 2007, JBR-BTR : organe de la Societe royale belge de radiologie (SRBR) = orgaan van de Koninklijke Belgische Vereniging voor Radiologie (KBVR),
Young Ki Lee, and Hyun Jung Jun, and Ji Hae Nahm, and Tae Seop Lim, and Ji Soo Park, and Joong Bae Ahn, and Sun Young Rha, and Hyun Cheol Chung, and Hwa Eun Oh, and Ji-Sun Song, and Woo Ick Yang, and Hyo Song Kim
August 2002, The Journal of the American Association of Gynecologic Laparoscopists,
Young Ki Lee, and Hyun Jung Jun, and Ji Hae Nahm, and Tae Seop Lim, and Ji Soo Park, and Joong Bae Ahn, and Sun Young Rha, and Hyun Cheol Chung, and Hwa Eun Oh, and Ji-Sun Song, and Woo Ick Yang, and Hyo Song Kim
January 1990, Cancer,
Copied contents to your clipboard!